Isolation and PCR detection of <Emphasis Type="Italic">Enterobacter sakazakii</Emphasis> in South African food products,specifically infant formula milks

Enterobacter sakazakii has recently been identified as an opportunistic pathogen. The current culture-dependent detection methods for these bacteria are time-consuming and in this study a PCR method for the detection of E. sakazakii in South African food products, including an internal amplification control (IAC) was developed. DNA was isolated and amplified from the products and they were plated on selective growth media after pre-enrichment and enrichment in Enterobacteriaceae enrichment broth. Four of the 22 products tested positive for the presence of E. sakazakii, confirmed by PCR detection and growth on selective media. The PCR method proved effective in detecting E. sakazakii in South African products after three days and could serve as an alternative for traditional microbiological techniques.     

Sleep architecture is related to the season of PSG recording in 8-month-old infants

ABSTRACT

To date, little is known about the impact of season on infant sleep. In higher latitudes, the duration of daily light time varies substantially between different seasons, and environmental light is one potential factor affecting sleep. In this cohort study, one-night polysomnography (PSG) was performed on 72 healthy 8-month-old infants in 2012 and 2013 to study the effect of season on the sleep architecture of young infants in Finland. The children were divided into four subgroups, according to the amount of light during their birth season and the amount of light during the season of the PSG recordings, corresponding to spring, summer, autumn, and winter. We found that the season of birth did not have an impact on the infants’ sleep architecture at 8 months of age, but the season of the PSG recording did have an effect on several sleep variables. In the PSGs conducted during the spring, there was less N3 sleep and more N2 sleep than in the PSGs conducted during the autumn. In addition, there was more fragmented sleep during spring than autumn. According to our data, the season has an effect on the sleep architecture of young infants and should, therefore, be considered when evaluating the PSG findings of young infants. The exact mechanisms behind this novel finding remain unclear, however. The findings imply that infants` sleep is affected by the season or light environment, as is the case in adult sleep. Since potential explanatory factors, such as direct natural or artificial light exposure and the melatonin levels of the infants, were not controlled, more research is needed in the future to better understand this phenomenon.     

High serum osteopontin levels in pediatric patients with high risk Langerhans cell histiocytosis

Osteopontin (OPN) acts as an osteoclast activator, a proinflammatory cytokine, and a chemokine attracting histiocytes/monocytes and is abundantly expressed in Langerhans cell histiocytosis (LCH). We investigated whether serum OPN levels are related to disease types in LCH. Fifty-eight newly diagnosed LCH patients were studied; eight with risk organ (liver, spleen and/or hematopoietic) involvements positive multisystem (MS+) disease, 27 with risk organ involvement negative multisystem (MS−) disease and 23 with single system (SS) disease. Pediatric patients with non-inflammatory disease (n = 27) were used as controls. All of patients with MS+ disease were younger than 3 years. Serum OPN levels and 44 kinds of humoral factors were measured by ELISA and Bio-Plex suspension array system, respectively. In the patients younger than 3 years, the median serum OPN level (interquartile range) was 240.3 ng/ml (137.6–456.0) in MS+ (n = 8); 92.7 ng/ml (62.0–213.8) in MS− (n = 14) and 72.5 ng/ml (55.6–94.0) in SS (n = 9) and 74.4 ng/ml (42.2–100.0) in control (n = 12). The OPN values were significantly higher in the MS+ group than the MS−, SS and control groups (p = 0.044, p = 0.001 and p = 0.002, respectively), but not different between the MS−, SS and control groups. In the patients older than 3 years, the median level of serum OPN (IQR) was 56.2 ng/ml (22.9–77.5) in MS− (n = 13), 58.9 ng/ml (31.0–78.7) in SS (n = 14) and 41.9 (28.9–54.1) in control (n = 15). These values did not differ significantly between each group. The serum OPN levels were positively correlated with the serum IL-6, CCL2, IL-18, IL-8 and IL-2 receptor concentration. OPN may be involved in risk organ dissemination and poor prognosis of LCH through the function as inflammatory cytokine/chemokine.     

婴幼儿喂养指数法评价6~23月龄婴幼儿喂养状况的临床价值

摘要 目的：探讨婴幼儿喂养指数法（ICFI）评价6~23月龄婴幼儿的喂养状况的临床价值。方法：于2015年6月至2016年2月，按照多阶段分层整群随机抽样的方法，抽取1418例6~23月龄婴幼儿作为调查对象。根据世界卫生组织（WHO）喂养建议建立喂养指数体系（包括母乳喂养、奶瓶喂养、膳食多样性、食物频率和喂养频率），进行ICFI评分。结果：本次共调查1418例婴幼儿，男766例（54.02 %），女652例（45.98 %）。6~8月龄组482例（33.99 %），9~11月龄组457例（32.23 %），12~23月龄组479例（33.78 %）。母乳喂养率为45.06 %，随月龄增加母乳喂养率降低（x²=234.486，P<0.05）。奶瓶喂养率为74.75 %，随月龄增加奶瓶喂养率升高（x²=75.671，P<0.05）。膳食多样性总满分率为67.42 %，满分率随月龄增加而增加（x²=154.146，P<0.05）。6~8、9~11月龄食物频率总满分率由高到低依次为谷类、蔬菜/水果、蛋/鱼/禽肉类、豆类及其制品、畜肉类；12~23月龄依次为奶类及其制品、蔬菜/水果、蛋/鱼/禽肉类、畜肉类、豆类及其制品。三个月龄组间食物频率评分随月龄增加而增加（F=1240.819，P<0.05）。喂养频率满分率为41.11 %（583/1418），随月龄增加而降低（x²=149.05，P<0.05）。结论：ICFI可客观地反映婴幼儿的喂养状况，目前6~23月龄婴幼儿喂养状况不容乐观，喂养状况随着月龄减小而变差。     

血乳酸在婴幼儿喘息性疾病中的临床意义

目的:探讨血乳酸在婴幼儿喘息性疾病中的临床意义。方法:随机选取我院2014年9月至2015年4月收治的5岁以内的支气管肺炎患儿245例,分为喘息组及非喘息组,比较其血乳酸水平。喘息组花儿根据年龄分为:A(≤12月)、B(12月年龄≤36月)及C(36月年龄≤60月)组,乳酸正常组(2.2 mmol/L)及乳酸升高组(≥2.2 mmol/L),比较其发病年龄、激素治疗量、治疗天数及住院费用差异。结果:与非喘息组比较,喘息组血乳酸值显著升高,且喘息组2.2 mmol/L≤Lac4.4 mmol/L患儿比例显著高于非喘息组(P0.05)。不同年龄亚组患儿的血乳酸值比较差异均具有统计学意义,年龄越小,乳酸值越高(P0.05)。与乳酸正常组比较,乳酸升高组患儿年龄小(P0.05),激素治疗量高(P0.05),但两组住院天数及治疗费用比较并无统计学差异(P0.05)。结论:喘息性疾病患儿年龄越小,血乳酸值明显升高,血乳酸值与喘息患儿激素治疗量有一定关系,故在指导婴幼儿喘息性疾病激素的合理应用及病情评估中有一定的参考意义。     

Predicting primate responses to “Stochastic” demographic events

Comparative approaches in contemporary primate behavioral ecology have tended to emphasize the deterministic properties of stochastic ecological variables. Yet, primate responses to ecological fluctuations may be mediated by the interactions among demographic processes at the levels of individuals, groups, and populations. In this paper I examine long-term data collected from June 1982–July 1998 on one expanding group of muriquis (Brachyteles arachnoides) at the Estação Biologica de Caratinga, Minas Gerais, Brazil to explore the demographic and life history correlates of reproductive seasonality and skewed infant sex ratios. Variation in the size of annual birth cohorts (≥2 infants) was positively related to variation in the annual distribution of births (r _s=0.96,n=10,p<0.01), indicating the importance of considering the effects that the number of reproductive females may have on interpretations of reproductive seasonality. The female-biased infants sex ratio documented from 59 births was attributed exclusively to multiparous mothers. Primiparous mothers produced comparable numbers of sons (n=6) and daughters (n=7), and were increasingly likely to produce daughters with each subsequent reproductive event. Seven of the 11 females that have produced≥3 infants to date exhibited biases in favor of daughters whereas only 1 was biased in favor of sons. Variation in female sensitivity to local resource competition at different stages of their life histories may account for the female-biased infant sex ration in this population.     

The relationship between female rank and reproductive parameters of the ringtailed lemur: a preliminary analysis

We used data from a 13-year field study of wild ringtailed lemurs to analyze the relationship between female rank and reproductive parameters. In medium and small groups there were no significant differences in birth rate, infant mortality rate, and the number of surviving infants between the female rank categories. On the other hand, in large sized groups low-ranked females had a smaller number of surviving infants than middle-ranked females. This suggests that in large sized groups, within-group competition lowered the values of reproductive parameters of low-ranked females. On the other hand, high and low-ranked females of small sized groups tended to have a smaller number of surviving infants than high-ranked females of medium sized groups and middle-ranked females of large sized groups. Between-group competition should lower the values of their reproductive parameters. In sum, these results fit the expectation from Wrangham’s (1980) inter group feeding competition model.     

Is there a dietary requirement for DHA in pregnancy?

The metabolic demand for docosahexaenoic acid (22:6 n-3, DHA) is increased during pregnancy because of the extra needs of the fetus, expanded maternal cell mass and placenta. In Western countries maternal dietary DHA intake in pregnancy is low and it is not clear whether adaptive metabolic mechanisms, such as increased DHA synthesis from precursor fatty acids, are capable of meeting the increased DHA need in pregnancy. Consequently randomized controlled trials are important to determine whether additional dietary DHA in pregnancy modifies maternal or infant health outcomes. The available randomized comparisons of DHA supplements vs placebo have assessed outcomes as diverse as maternal depression, infant visual acuity and development, and infant growth and allergy. The outcomes of these trials have not been conclusive because they have often been limited by small sample size. On the other hand, large-scale trials assessing marine oil supplementation with large doses indicate that DHA supplementation in pregnancy is safe.     

Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized controlled trials

The question of whether a dietary supply of docosahexaenoic acid (DHA) and arachidonic acid (ARA) imparts advantages to visual or cognitive development in term infants has been debated for many years. DHA and ARA are present in human milk, and nursing infants consume these fatty acids needed for rapid synthesis of cell membranes, particularly neural cells. The reported mean DHA and ARA levels of human milk worldwide are 0.32% and 0.47% of total fatty acids, respectively. Prior to 2002 in the US, formula-fed infants did not receive these fatty acids and relied solely on endogenous conversion of the dietary essential omega-3 (n-3) and omega-6 (n-6) fatty acids, α-linolenic and linoleic acids, to DHA and ARA, respectively. Formula-fed infants were found to have significantly less accretion of DHA in brain cortex after death than breastfed infants. Numerous studies have found positive correlations between blood DHA levels and improvements in cognitive or visual function outcomes of breastfed and formula-fed infants. Results of randomized controlled clinical trials of term formula-fed infants evaluating functional benefits of dietary DHA and ARA have been mixed, likely due to study design heterogeneity. A comparison of visual and cognitive outcomes in these trials suggests that dietary DHA level is particularly relevant. Trials with formulas providing close to the worldwide human milk mean of 0.32% DHA were more likely to yield functional benefits attributable to DHA. We agree with several expert groups in recommending that infants receive at least 0.3% DHA, with at least 0.3% ARA, in infant feedings; in addition, some clinical evidence suggests that an ARA:DHA ratio greater than 1:1 is associated with improved cognitive outcomes.     

Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations

The accretion of docosahexaenoic acid (DHA) in membranes of the central nervous system is required for the optimum development of retina and brain functions. DHA status is determined by the dietary intake of n-3 polyunsaturated fatty acids (PUFA), both the metabolic precursor α-linolenic acid (α-LNA) and DHA. Clinical studies have shown that feeding term or premature infants with formula low in total n-3 PUFA may alter the maturation of visual acuity. Moreover, feeding infants over the first 6 mon of life with formula containing adequate α-LNA, but no DHA, did not sustain the same cerebral accretion of DHA as that of breast-fed infants. Whether lower DHA accretion in brain of formula-fed term infants impairs neurophysiological performances is not clearly established. Contradictory data have been published, possibly owing to confounding factors such as maternal intakes and/or genetic variations in PUFA metabolism. Nevertheless, a large corpus of data is in favor of the recommendation of regular dietary intakes of DHA (during at least the first 6 mon of life) and suggest that DHA should be added in formulas at the level generally found in human milk (0.2-0.3 wt% of total fatty acids). The maternal intake of n-3 PUFA during pregnancy and lactation is also crucial, since the n-3 PUFA are provided during perinatal development through placental transfer and maternal milk, which determines the DHA status of the newborn and consequently impacts on post-natal development of brain and visual functions. Whether more clinical studies are needed to control and improve the impact of DHA maternal intakes on the progeny’s neurodevelopment, several commissions recommended by precaution that DHA average intake for pregnant and lactating women should be of 200-300 mg/day.